Estimates Revisions Beta Bionics, Inc. CBOE
Stocks
BBNX
US08659B1026
Advanced Medical Equipment & Technology
|
Market Closed -
CBOE
01:29:51 16/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 19.22 USD | +14.95% |
|
-14.04% | -45.09% |
| 12/08 | BofA Securities Adjusts Price Target on Beta Bionics to $18 From $15.50 | MT |
| 11/08 | BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50 | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Beta Bionics, Inc.(BBNX)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Beta Bionics, Inc.(BBNX)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Beta Bionics, Inc.(BBNX)
EBIT
Dividend / Share (DPS)
Data source:
Beta Bionics, Inc.(BBNX)
Cash or Net Debt
- Stock Market
- Stocks
- BBNX Stock
- BBNX Stock
- Consensus Beta Bionics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
